| Tumor cell-induced platelet aggregation as an emerging therapeutic target for cancer therapy W Strasenburg, J Jóźwicki, J Durślewicz, B Kuffel, MP Kulczyk, ... Frontiers in Oncology 12, 909767, 2022 | 36 | 2022 |
| Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers MWS Paweł Sadłecki1, Marek Grabiec , Dariusz Grzanka , Jakub Jóźwicki ... Journal of Ovarian Research, 2019 | 19 | 2019 |
| Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers P Sadlecki, J Jóźwicki, P Antosik, M Grabiec Tumor Biology 40 (6), 1010428318784807, 2018 | 16 | 2018 |
| HER2, NF‐κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters M Smolińska, D Grzanka, P Antosik, A Kasperska, I Neska-Długosz, ... Disease Markers 2019 (1), 6315936, 2019 | 14 | 2019 |
| Expression of Selected Epithelial‐Mesenchymal Transition Transcription Factors in Endometrial Cancer P Sadłecki, J Jóźwicki, P Antosik, M Walentowicz-Sadłecka BioMed Research International 2020 (1), 4584250, 2020 | 13 | 2020 |
| Prognostic significance of TLR2, SMAD3 and localization-dependent SATB1 in stage I and II non–small-cell lung cancer patients J Durślewicz, A Klimaszewska-Wiśniewska, J Jóźwicki, P Antosik, ... Cancer control 28, 10732748211056697, 2021 | 11 | 2021 |
| Prognostic significance of MATR3 in stage I and II non-small cell lung cancer patients J Durślewicz, A Klimaszewska-Wiśniewska, J Jóźwicki, P Antosik, ... Journal of Cancer Research and Clinical Oncology 148 (12), 3313-3322, 2022 | 7 | 2022 |
| High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients J Durślewicz, J Jóźwicki, A Klimaszewska-Wiśniewska, A Zielińska, ... Discover Oncology 13 (1), 106, 2022 | 5 | 2022 |
| The role of early diagnosis of emphysematous cystitis: A case report and literature review F Kowalski, J Adamowicz, J Jozwicki, D Grzanka, T Drewa Urology Case Reports 36, 101581, 2021 | 2 | 2021 |
| Expression of PD-L1 in tumor and immune system cells affects the survival of patients with urinary bladder cancer M Matusiak, J Dzierżawski, J Jóźwicki, J Starzyński, J Misiak, AA Brożyna, ... Medical Research Journal 4 (3), 142-147, 2019 | 1 | 2019 |
| L1cam expression in endometrial cancer P Sadłecki, J Jóźwicki, P Antosik, D Grzanka, M Walentowicz-Sadłecka European Journal of Obstetrics and Gynecology and Reproductive Biology 293 …, 2024 | | 2024 |
| Discover Oncology J Durślewicz, J Jóźwicki, A Klimaszewska‑Wiśniewska, A Zielińska, ... | | 2022 |
| Research Article HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters M Smolińska, D Grzanka, P Antosik, A Kasperska, I Neska-Długosz, ... | | 2019 |
| The effect of RORa expression on the development of biological malignancy of urinary bladder cancer J Starzyński, J Jóźwicki, M Matusiak, J Dzierżawski, J Misiak, AA Brożyna, ... Medical Research Journal 4 (3), 129-135, 2019 | | 2019 |
| The type of distribution of PD-L1 positive immune cells and PD-L1 expression in tumor cells correlate with the development of non-classical differentiation in urinary bladder … M Matusiak, J Starzyński, J Jóźwicki, J Dzierżawski, J Misiak, W Jóźwicki Medical Research Journal 4 (3), 136-141, 2019 | | 2019 |
| Evaluation of the importance of selected obesity-inflammation-tumor axis proteins in the group of patients with cancer of the endometrium M Gagat, P Antosik, A Klimaszewska-Wisniewska, J Jozwicki, A Grzanka, ... INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 42, S42-S42, 2018 | | 2018 |
